As of Nov 27
| +0.10 / +2.48%|
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +868.52% increase from the last price of 4.13.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.